Berlin, June 28, 2022 – Bayer today revealed the launch of Calantic™ Digital Solutions, a brand-new platform providing access to digital applications, consisting of expert system (AI) made it possible for programs for medical imaging. The offering includes tools which assist radiologists and their groups to enhance prioritization, sore detection, metrology, and performance. By supplying access to AI radiology applications through the Calantic Digital Solutions platform Bayer will broaden its thorough portfolio beyond contrast media, medical gadgets, software application and services. The brand-new platform will support health care specialists at all phases of their work, from medical diagnosis through treatment of their clients.
“AI has the prospective to change health care, and especially in medical imaging it can turn the growing quantities of information into value-adding insights to support radiologists and their groups in their decision-making”, stated Dr. Ryan Lee, Chair, Department of Radiology, Einstein Healthcare Network, Philadelphia, USA. “It is vital to drive development in this location and widen access to digital tools that can assist resolve the increasing need for services which enhance the speed and precision of medical diagnoses.”
“As a leader in essential Radiology locations and structure on our deep medical understanding throughout a plethora of diagnostic and restorative locations, Calantic Digital Solutions highlights our dedication to continue speeding up development for the advantage of clients and their doctors”, stated Gerd Krueger, Head of Radiology, Bayer Pharmaceuticals. “With Calantic Digital Solutions, we are going into the fastest growing section in the radiology market and taking the next action on our method from an item service provider to an option supplier, following our objective to offer a community of third-party and Bayer items to provide state-of-the art disease-oriented services for radi